About Kuveda
Kuveda is a Healthcare company based in San Jose (United States) founded in 2013. SaaS tools for analyzing cancer patients molecular profiles are provided. Kuveda has raised $70 thousand across 1 funding round. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Denali Therapeutics, GRAIL and MiRagen; 3 of its 3 listed competitors have raised funding.
Company details
Kuveda was founded in 2013 in San Jose, United States, within the health technology sector. SaaS tools are offered for examining molecular profiles of cancer patients, including biomarkers, proteins, genes, pathways, and specific molecules. Evidence-based personalized treatment options are supported for oncologists. Curated data from pharmacological, biological, toxicological, and genetic sources are integrated to produce detailed reports on therapeutic possibilities.
- Headquarters San Jose, United States
- SectorsHealthcare
- Website kuveda.com
- Social LinkedIn X YouTube
- Total Equity Funding$70K (USD)
in 1 rounds
- Latest Funding Round$70K (USD), Angel Round
Jun 2013
Apps and channels of Kuveda
its YouTube channel JokerMartini has 1.47K subscribers and 30 videos.
Videos from Kuveda
The most watched videos on Kuveda's YouTube channel, JokerMartini (1.47K subscribers). Click a video to play it here.
More on JokerMartini.
Funding Insights of Kuveda
Kuveda has successfully raised a total of $70K through 1 strategic funding round. The most recent funding activity was a Angel Round of $70 thousand completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $70,000
- Total Rounds 1
- Last Round Angel Round — $70,000
- First Round $70,000
(Jun 2013)
All 1 funding rounds of Kuveda with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2013 | $70,000 | Angel Round | – | – | – |
People of Kuveda
1 people are tracked at Kuveda (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jasvir Zonobi | CEO | Leadership |
Complete people profiles for Kuveda
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Kuveda
2 dated milestones of Kuveda, from founding to its latest funding, stage changes and deals.
- Founded Kuveda is founded.
- Funding First funding round of $70K.
Competitors of Kuveda
Kuveda has 3 listed competitors in our database, 3 of them funded. They include Denali Therapeutics, GRAIL and MiRagen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| miragen.com | 2007 | Boulder, United States | $111.29M | 92 | MicroRNA-based therapeutics are developed for treating multiple diseases. |
Detailed competitors of Kuveda
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kuveda
The website of Kuveda (kuveda.com) receives about 1K visits a month.
- Monthly visits1K
▲ 1319.3% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Kuveda (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kuveda
Kuveda was founded in 2013.
Kuveda is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Kuveda is a funded company, having raised a total of $70K across 1 funding round to date. The company's 1st funding round was a Angel Round of $70K, raised on Jun 2013.
Kuveda was founded in 2013 in San Jose, United States, within the health technology sector. SaaS tools are offered for examining molecular profiles of cancer patients, including biomarkers, proteins, genes, pathways, and specific molecules. Evidence-based personalized treatment options are supported for oncologists. Curated data from pharmacological, biological, toxicological, and genetic sources are integrated to produce detailed reports on therapeutic possibilities.
Kuveda's top competitors include GRAIL, Denali Therapeutics and MiRagen.